Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Amino Acid Conferred Protection against Melphalan: Interference with Leucine Protection of Melphalan Cytotoxicity by the Basic Amino Acids in Cultured Murine L1210 Leukemia Cells

DAVID T. VISTICA, JANE N. TOAL and MARCO RABINOVITZ
Molecular Pharmacology November 1978, 14 (6) 1136-1142;
DAVID T. VISTICA
Laboratory of Medicinal Chemistry and Biology, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JANE N. TOAL
Laboratory of Medicinal Chemistry and Biology, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARCO RABINOVITZ
Laboratory of Medicinal Chemistry and Biology, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

This article has a correction. Please see:

  • Erratum for Volume 14, No. 6, November 1978 - May 01, 1979

Abstract

Melphalan cytotoxicity to murine L1210 leukemia cells in culture is influenced by the amino acid composition of the incubation medium. Deletion of glutamine or leucine from RPMI 1630 medium increased the cytotoxicity produced during a 35 min exposure of L1210 cells to melphalan by 10-fold and 2-fold, respectively, indicating that a substantial proportion of the protection afforded L1210 cells from melphalan cytotoxicity in an amino acid environment can be attributed to these amino acids. However, protection from melphalan cytotoxicity in cells first incubated with leucine in a balanced salt solution containing bovine serum albumin and glucose was 10 times better than that in cells incubated with leucine in RPMI 1630 medium containing all amino acids except glutamine. This difference was due to an increase in the accumulation of intracellular melphalan in medium containing leucine and the basic amino acids. The increases in intracellular drug and resulting cytotoxicity decrease with increasing carbon chain length within the arginine homologous series (α-amino-γ-guanidinobutyric acid > arginine > homoaginine). However, the lowest arginine homologue, α-amino-β-guanidinopropionic acid, was ineffective. Maximum promotion of melphalan cytotoxicity by β-amino-γ-guanidinobutyric acid occurred at concentrations equimolar with leucine and was not substantially influenced by the length of prior incubation with the homologue. Interaction between melphalan and the basic amino acids with the leucine-preferring transport system in L1210 cells plays a significant role in melphalan cytotoxicity.

ACKNOWLEDGMENTS The authors express their appreciation to Ms. Charlotte Thomas for preparation of the manuscript.

  • Copyright © 1978 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 14, Issue 6
1 Nov 1978
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Amino Acid Conferred Protection against Melphalan: Interference with Leucine Protection of Melphalan Cytotoxicity by the Basic Amino Acids in Cultured Murine L1210 Leukemia Cells
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Amino Acid Conferred Protection against Melphalan: Interference with Leucine Protection of Melphalan Cytotoxicity by the Basic Amino Acids in Cultured Murine L1210 Leukemia Cells

DAVID T. VISTICA, JANE N. TOAL and MARCO RABINOVITZ
Molecular Pharmacology November 1, 1978, 14 (6) 1136-1142;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Amino Acid Conferred Protection against Melphalan: Interference with Leucine Protection of Melphalan Cytotoxicity by the Basic Amino Acids in Cultured Murine L1210 Leukemia Cells

DAVID T. VISTICA, JANE N. TOAL and MARCO RABINOVITZ
Molecular Pharmacology November 1, 1978, 14 (6) 1136-1142;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAAR Molecular Identity in Oligodendrocytes
  • Editing TOP2α Intron-19 5′ SS Circumvents Drug Resistance
  • SerpinA3N and drug induced liver injury
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics